Lv4
550 积分 2023-08-16 加入
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050
1个月前
已完结
Rethinking GOLD E: The Significance of a Single Moderate Exacerbation in COPD
2个月前
已关闭
Prognostic Significance of Mild Exacerbations or 1 Moderate Exacerbation in COPD
2个月前
已关闭
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: A multicenter, randomized, double-blind, Phase 3A Clinical Trial (NIMBLE)
2个月前
已完结
Validation of COPD Population Screener Questionnaire in Chinese Population: A National Multicenter Study
3个月前
已完结
Long COVID and symptom persistence in post-discharge omicron patients: Insights into C-reactive protein
3个月前
已完结
C-Reactive Protein to Serum Albumin Ratio as a Novel Biomarker to Predict Prognosis in Patients with Chronic Obstructive Pulmonary Disease
3个月前
已完结
Distribution of Blood Eosinophil Count in the Chinese General Population
3个月前
已完结
Vasoplegia Syndrome After Cardiac Surgery
4个月前
已关闭
皖公网安备34019202002308
